CN Patent

CN111527067B — 1－[5－(2－氟苯基)－1－(吡啶－3－基磺酰基)－1h－吡咯－3－基]－n－甲基甲胺单富马酸盐的制造法

Assigned to Sofac Japan Co ltd · Expires 2024-06-25 · 2y expired

What this patent protects

本发明涉及基于甲酰化、脱保护反应的5－(2－氟苯基)－1H－吡咯－3－甲醛的制造方法以及基于磺酰基化等的1－[5－(2－氟苯基)－1－(吡啶－3－基磺酰基)－1H－吡咯－3－基]－N－甲基甲胺单富马酸盐的制造。

USPTO Abstract

本发明涉及基于甲酰化、脱保护反应的5－(2－氟苯基)－1H－吡咯－3－甲醛的制造方法以及基于磺酰基化等的1－[5－(2－氟苯基)－1－(吡啶－3－基磺酰基)－1H－吡咯－3－基]－N－甲基甲胺单富马酸盐的制造。

Drugs covered by this patent

vonoprazan-fumarate (VONOPRAZAN FUMARATE)

Patent Metadata

Patent number: CN111527067B
Jurisdiction: CN
Classification: —
Expires: 2024-06-25
Drug substance claim: No
Drug product claim: No
Assignee: Sofac Japan Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.